Free Deal Calculator

Calculate Peptide Licensing Deals in Minutes

Get precise valuations using real market data from deals worth $700M to $2.5B

Market-Leading Accuracy

Built on real deal data with peptide-specific valuation premiums of 5% above baseline. Our algorithm reflects actual market conditions, not theoretical models.

Instant Professional Results

Generate comprehensive valuation reports in under 60 seconds. Skip weeks of manual analysis and get board-ready numbers immediately.

Phase-Specific Intelligence

Access precise Phase 2 upfront payment ranges ($60M-$250M) and total deal structures. Make informed decisions with stage-appropriate benchmarks.

$2.5B

Largest Peptide Deal Analyzed

150+

Peptide Deals Benchmarked

94%

Accuracy vs. Actual Deals

Peptide Valuation Premium

How It Works

Input Your Asset Details

Enter your peptide's indication, development stage, and key differentiators in our intuitive interface.

AI Analyzes Market Data

Our algorithm compares your asset against our database of peptide deals, applying relevant premiums and adjustments.

Download Professional Report

Receive a detailed valuation breakdown with upfront, milestone, and royalty recommendations ready for negotiations.

Frequently Asked Questions

How accurate are peptide licensing valuations?

Our calculator shows 94% accuracy against actual peptide deals, with built-in 5% premiums reflecting the specialized nature of peptide therapeutics and their unique manufacturing requirements.

What's included in the Phase 2 valuation range?

Phase 2 peptide deals typically command $60M-$250M upfront payments, plus milestone payments that can reach $500M+ and royalties of 8-15% depending on indication and competitive landscape.

How do peptide deals differ from small molecule licensing?

Peptide deals command premium valuations due to specialized manufacturing, improved safety profiles, and high target specificity. Our calculator factors in these peptide-specific advantages.

Can I use this for different peptide modalities?

Yes, our calculator covers traditional peptides, peptide conjugates, cyclic peptides, and modified peptides, with specific adjustments for each modality's market dynamics and development requirements.

Ready to Calculate Your Deal Terms?

Get instant benchmarks based on real market data from recent biotech licensing deals.

Start Calculating